ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 156215 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 156215; 2) Community: the network communities that were significantly associated with the response to NSC 156215; 3) Molecule: the relationships between components within communities and NSC 156215; 4) MDR: the compounds that were significantly associated with the NSC 156215.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0321614375606959 -0.23955973
NSC 725098 Null 0.0321614375606959 0.22988702
NSC 743532 Null 0.0321614375606959 -0.031865661
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0321614375606959 0.29177949
NSC 752346 Null 0.0321614375606959 0.16627375
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0321614375606959 0.086508737
NSC 753598 Null 0.0321614375606959 0.19145307
NSC 756483 SB-742864 0.0321614375606959 0.1461426
NSC 93819 Depakine 0.0321614375606959 0.12734627
NSC 762888 6-Chloro-5-[2-(4H-1,2,4-triazol-4-yl)ethyl]-1,3-dihydro-2H-indol-2-one 0.0348927754043159 -0.22032704
Total:105  Current:75    [First] [Prev] [Next] [Last]